Preclinical evidence of the enhanced effectiveness of combined rapamycin and <scp>AICAR</scp> in reducing kidney cancer
Sitai Liang(The University of Texas at San Antonio Health Science Center), Samy L. Habib(The University of Texas at San Antonio Health Science Center)
Cited by 10
Related Papers
Insight into mechanism of oxidative DNA damage in angiomyolipomas from TSC patients
|Molecular Cancer|2009|17
Novel mechanism of regulation of fibrosis in kidney tumor with tuberous sclerosis
|Molecular Cancer|2013|16